DCNP

DCNP is a research compound that activates NPR-B/C receptors, triggering cGMP signaling to modulate vascular tone and exert anti-hypoxic effects. It demonstrates antifibrotic activity by suppressing tumor stroma and can enhance anti-tumor immunity through the upregulation of cytotoxic lymphocytes and dendritic cells in preclinical models.